Cerebrospinal fluid pterins and folates in Aicardi-Goutières syndrome: A new phenotype

Neurology

Volumn 61, Issue 5, 2003, Pages 642-647

  Blau, N ^a   Bonafe L ^b   Krageloh Mann I ^b   Thony B ^a   Kierat, L ^a   Hausler M ^b   Ramaekers, V ^b  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; 5 METHYLTETRAHYDROFOLIC ACID; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALPHA INTERFERON; BIOPTERIN; CYANOCOBALAMIN; DNA; FOLIC ACID DERIVATIVE; FOLINIC ACID; GAMMA INTERFERON; GLUCOSE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; HOMOVANILLIC ACID; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; NEOPTERIN; PTERIN DERIVATIVE; TETRAHYDROBIOPTERIN; TUMOR NECROSIS FACTOR ALPHA;

AICARDI GOUTIERES SYNDROME; ARTICLE; BASAL GANGLION; CASE REPORT; CEREBROSPINAL FLUID LEVEL; COMPUTER ASSISTED TOMOGRAPHY; DNA SEQUENCE; DYSKINESIA; FEMALE; HUMAN; HUMAN CELL; INFANT; MALE; MENTAL DEFICIENCY; MICROCEPHALY; MOTOR RETARDATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEIZURE; SPASTICITY; WHITE MATTER;

EID: 0041834652     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000082726.08631.E7     Document Type: Article

References (26)

1. Aicardi J, Goutières F. A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. Ann Neurol 1984;15:49-54.
2. Aicardi J. Aicardi-Goutières syndrome: special type early-onset encephalopathy. Eur J Paediatr Neurol 2002; 6(suppl A): A1-7.
3. McEntagart M, Kamel H, Lebon P, King MD. Aicardi- Goutières syndrome: an expanding phenotype. Neuropediatrics 1998;29:163-167.
4. Lanzi G, Fazzi E, D'Arrigo S. Aicardi-Goutières syndrome: a description of 21 new cases and a comparison with the literature. Eur J Paediatr Neurol 2002;6(suppl A):A9-22.
5. Lebon P, Meritet JF, Krivine A, Rozenberg F. Interferon and Aicardi-Goutières syndrome. Eur J Paediatr Neurol 2002;6(suppl A): A47-53; discussion A55-48, A77-86.
6. Longhi R, Valsasina R, Butte C, et al. Cranial computerized tomography in dihydropteridine reductase deficiency. J Inherit Metab Dis 1985;8:109-112.
7. Woody RC, Brewster MA, Glasier C. Progressive intracranial calcification in dihydropteridine reductase deficiency prior to folinic acid therapy. Neurology 1989;39:673-675.
8. Lanzkowsky P, Erlandson ME, Bezan AI. Isolated defect of folic acid absorption associated with mental retardation and cerebral calcification. Blood 1969;34:452-465.
9. Curtius HC, Blau N, Kuster T. Pterins. In: Hommes FA, ed. Techniques in diagnostic human biochemical genetics. New York: Wiley-Liss, 1991;377-396.
10. Blau N, Thöny B, Renneberg A, et al. Variant of dihydropteridine reductase deficiency without hyperphenylalaninemia: effect of oral phen$nylalanine loading. J Inherit Metab Dis 1999;22:216-220.
11. Bonafé L, Thöny B, Leimbacher W, Kierat L, Blau N. Diagnosis of dopa-responsive dystonia and other tetrahydrobiopterin disorders by the study of biopterin metabolism in fibroblasts. Clin Chem 2001;47: 477-485.
12. Blau N, Thöny B, Cotton RGH, Hyland K. Disorders of tetrahydrobiopterin and related biogenic amines. In: Scriver CR, Beaudet AL, Sly WS, et al., eds. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill, 2001;1725-1776.
13. Chen CC, Chiu PC, Shieh KS. Type 1 GM1 gangliosidosis with basal ganglia calcification: a case report. Zhonghua Yi Xue Za Zhi (Taipei) 1999;62:40-45.
14. Allard JC, Tilak S, Carter AP. CT and MR of MELAS syndrome. AJNR Am J Neuroradiol 1988;9:1234-1238.
15. Coskun T, Besim A, Ozalp I, Erylimaz M, Intracranial calcifications in dihydropteridine reductase deficiency. Turk J Pediatr 1990;32:259-264.
16. Goldstein DS, Hahn SH, Holmes C, et al. Monoaminergic effects of folinic acid, L-DOPA, and 5-hydroxytryptophan in dihydropteridine reductase deficiency. J Neurochem 1995;64:2810-2813.
17. Miladi N, Larnaout A, Dhondt JL, et al. Dihydropteridine reductase deficiency in a large consanguineous Tunisian family: clinical, biochemical, and neuropathologic findings. J Child Neurol 1998;13:475-480.
18. Lipson AH, Earl JW, Wilcken B, et al. Successful treatment of dihydropteridine reductase deficiency, with an interesting effect of 5-hydroxytryptophan deficiency on sleep patterns. J Inherit Metab Dis 1991;14:49-52.
19. Blau N, Heizmann CW, Sperl W, et al. Atypical (mild) forms of dihydropteridine reductase deficiency-neurochemical evaluation and mu-tation detection. Pediatr Res 1992;32:726-730.
20. Ponzone A, Guardamagna O, Ferraris S, et al. Neurotransmitter therapy and diet in malignant phenylketonuria. Eur J Pediatr 1987;146:93-94.
21. Thöny B, Auerbach G, Blau N. Tetrahydrobiopterin biosynthesis, regeneration, and functions. Biochem J 2000;347:1-26.
22. Schoedon G, Troppmair J, Adolf G, Huber C, Niederwieser A. Interferon-gamma enhances biosynthesis of pterins in peripheral blood mononuclear cells by induction of GTP-cyclohydrolase I activity. J Interferon Res 1986;6:697-703.
23. Werner ER, Bahrami S, Heller R, Werner-Fellmayer G. Bacterial lipopolysaccharide down-regulates expression of GTP cyclohydrolase I feed-back regulatory protein. J Biol Chem 2002;277:10129-10133.
24. Leitner KL, Meyer M, Leimbacher W, et al. The low tetrahydrobiopterin biosynthetic capacity of human monocytes is caused by exon skipping in 6-pyruvoyl tetrahydropterin synthase. Biochem J 2003;278:28303-28311.
25. Hyland K, Smith I, Bottiglieri T, et al. Demyelination and decreased S-adenosylmethionine in 5,10-methylenetetrahydrofolate reductase deficiency. Neurology 1988;38:459-462.
26. Kaufman S. Some metabolic relationships between biopterin and folate: implications for the "methyl trap hypothesis." Neurochem Res 1991;16: 1031-1036.